DCM
GILD icon

Dialectic Capital Management’s Gilead Sciences GILD Stock Holding History

Dialectic Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-60,000
Closed -$6.07M – 121
2015
Q4 		$6.07M Buy
60,000
+43,000
+253% +$4.47M 1.75% 8
2015
Q3 		$1.67M Buy
+17,000
New +$1.89M 0.54% 54
2015
Q2 		– Sell
-15,000
Closed -$1.47M – 208
2015
Q1 		$1.47M Sell
15,000
-20,000
-57% -$2.03M 0.26% 117
2014
Q4 		$3.3M Buy
+35,000
New +$3.62M 0.62% 48

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dialectic Capital Management's GILD Position: Q4 2015 in Review

Dialectic Capital Management sold out of Gilead Sciences (GILD) in Q4 2015, closing a stake of 7,000 shares — an estimated $728K sold.

Dialectic Capital Management first reported a position in GILD in Q3 2015 and held it in 1 quarter. The position peaked at $687K in Q3 2015. 1,630 funds tracked by Wall St. Rank hold GILD as of Q4 2015.

  • Dialectic Capital Management reported no remaining Gilead Sciences position as of Q4 2015 after selling out during the quarter.
  • Dialectic Capital Management sold 7,000 Gilead Sciences shares in Q4 2015, an estimated $728K.
  • Dialectic Capital Management first reported a position in Gilead Sciences in Q3 2015 and held it in 1 quarter.
  • Dialectic Capital Management's Gilead Sciences position peaked at $687K in Q3 2015.
  • 1,630 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2015.

Based on Dialectic Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.